BDSX
Price
$10.34Alerts
Change
+$1.81 (+21.22%)
Updated
Nov 9 closing price
Capitalization
90M
126 days until earnings call
Intraday BUY SELL Signals
RVTY
Price
$160.72Alerts
Change
+$5.61 (+3.62%)
Updated
Nov 9 closing price
Capitalization
17.31B
86 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BDSX vs RVTY

BDSX vs RVTY Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BDSX vs. RVTY commentary
Nov 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDSX is a Hold and RVTY is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for BDSX with price predictions
Nov 09, 2026

Momentum Indicator for BDSX turns negative, indicating new downward trend

BDSX saw its Momentum Indicator move below the 0 level on October 30, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned negative. In 78 of the 86 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

BDSX moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for BDSX crossed bearishly below the 50-day moving average on October 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 83%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BDSX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for BDSX entered a downward trend on November 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +12.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where BDSX advanced for three days, in 202 of 237 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

BDSX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 52 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.843) is normal, around the industry mean (67.298). P/E Ratio (-2.752) is within average values for comparable stocks, (4.239). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.463) is also within normal values, averaging (9.775).

The Tickeron Price Growth Rating for this company is 66 (best 1 - 100 worst), indicating fairly steady price growth. BDSX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BDSX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.

A.I.Advisor
a Summary for RVTY with price predictions
Nov 09, 2026

Momentum Indicator for RVTY turns positive, indicating new upward trend

RVTY saw its Momentum Indicator move above the 0 level on November 09, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 88 similar instances where the indicator turned positive. In 65 of the 88 cases, the stock moved higher in the following days. The odds of a move higher are at 74%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a +6.56% 3-day Advance, the price is estimated to grow further. Considering data from situations where RVTY advanced for three days, in 200 of 300 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.

The Aroon Indicator entered an Uptrend today. In 112 of 186 cases where RVTY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 60%.

Bearish Trend Analysis

The 10-day RSI Indicator for RVTY moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 20 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 65%.

The Moving Average Convergence Divergence Histogram (MACD) for RVTY turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 35 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 73%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RVTY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.

RVTY broke above its upper Bollinger Band on October 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 3 (best 1 - 100 worst), indicating outstanding price growth. RVTY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 79 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.394) is normal, around the industry mean (67.298). P/E Ratio (74.572) is within average values for comparable stocks, (4.239). Projected Growth (PEG Ratio) (0.734) is also within normal values, averaging (3.473). Dividend Yield (0.002) settles around the average of (0.002) among similar stocks. P/S Ratio (5.656) is also within normal values, averaging (9.775).

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 86 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RVTY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.

FUNDAMENTALS RATINGS
BDSX vs RVTY: Fundamental Ratings
BDSX
RVTY
OUTLOOK RATING
1..100
7228
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
79
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10086
PRICE GROWTH RATING
1..100
663
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
1385

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BDSX's Valuation (52) in the null industry is in the same range as RVTY (79) in the Medical Specialties industry. This means that BDSX’s stock grew similarly to RVTY’s over the last 12 months.

BDSX's Profit vs Risk Rating (100) in the null industry is in the same range as RVTY (100) in the Medical Specialties industry. This means that BDSX’s stock grew similarly to RVTY’s over the last 12 months.

RVTY's SMR Rating (86) in the Medical Specialties industry is in the same range as BDSX (100) in the null industry. This means that RVTY’s stock grew similarly to BDSX’s over the last 12 months.

RVTY's Price Growth Rating (3) in the Medical Specialties industry is somewhat better than the same rating for BDSX (66) in the null industry. This means that RVTY’s stock grew somewhat faster than BDSX’s over the last 12 months.

RVTY's P/E Growth Rating (8) in the Medical Specialties industry is in the same range as BDSX (9) in the null industry. This means that RVTY’s stock grew similarly to BDSX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BDSXRVTY
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
65%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
67%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
74%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
73%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
68%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
66%
Advances
ODDS (%)
Bullish Trend 13 days ago
85%
Bullish Trend 1 day ago
67%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 6 days ago
67%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
67%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
60%
COMPARISON
Comparison
Nov 10, 2026
Stock price -- (BDSX: $10.34 vs. RVTY: $160.72)
Brand notoriety: BDSX and RVTY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BDSX: 620% vs. RVTY: 84%
Market capitalization -- BDSX: $90M vs. RVTY: $17.31B
BDSX [@Medical Specialties] is valued at $90M. RVTY’s [@Medical Specialties] market capitalization is $17.31B. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The average market capitalization across the [@Medical Specialties] industry is $20.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDSX’s FA Score shows that 1 FA rating(s) are green while RVTY’s FA Score has 2 green FA rating(s).

  • BDSX’s FA Score: 1 green, 4 red.
  • RVTY’s FA Score: 2 green, 3 red.
According to our system of comparison, RVTY is a better buy in the long-term than BDSX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDSX’s TA Score shows that 4 TA indicator(s) are bullish while RVTY’s TA Score has 4 bullish TA indicator(s).

  • BDSX’s TA Score: 4 bullish, 5 bearish.
  • RVTY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RVTY is a better buy in the short-term than BDSX.

Price Growth

BDSX (@Medical Specialties) experienced а -52.53% price change this week, while RVTY (@Medical Specialties) price change was +6.02% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.11%. For the same industry, the average monthly price growth was -5.15%, and the average quarterly price growth was +40.44%.

Reported Earning Dates

BDSX is expected to report earnings on Mar 16, 2027.

RVTY is expected to report earnings on Feb 04, 2027.

Industries' Descriptions

@Medical Specialties (-1.11% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

View a ticker or compare two or three
Interact to see
Advertisement

RVTY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVTY has been closely correlated with TMO. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if RVTY jumps, then TMO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVTY
1D Price
Change %
RVTY100%
+3.62%
TMO - RVTY
70%
Closely correlated
+3.87%
A - RVTY
63%
Loosely correlated
+3.10%
AZTA - RVTY
63%
Loosely correlated
+4.57%
BIO - RVTY
60%
Loosely correlated
+1.77%
WAT - RVTY
60%
Loosely correlated
+4.17%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FLKR47.181.71
+3.76%
Franklin FTSE South Korea ETF (FLKR)
BYRE27.590.54
+1.99%
Principal Real Estate Active Opportunities ETF (BYRE)
JXI84.421.61
+1.94%
iShares Global Utilities ETF (JXI)
RCGE31.340.55
+1.79%
RockCreek Global Equality ETF (RCGE)
CRY13.69-0.12
-0.90%
GraniteShares YieldBOOST CRCL ETF (CRY)